Tag: NuCana

NuCana plc finds itself navigating turbulent waters as promising clinical developments clash with concerning technical indicators. The biopharmaceutical company's latest ...

NuCana plc witnessed a significant sell-off on Thursday, with its shares plunging 7.92 percent to close at $3.49. This sharp ...

NuCana plc's stock continues to experience significant downward pressure, with shares declining 1.75% during the latest trading session to close ...

NuCana plc witnessed dramatic trading activity on Wednesday, with its shares swinging by more than 15% before ultimately closing nearly ...

A potentially transformative moment for NuCana shareholders arrives today as the European Society for Medical Oncology (ESMO) prepares to disclose ...

NuCana shares experienced a severe downturn during the latest trading session, recording double-digit percentage losses that rattled market participants. The ...

Biopharmaceutical company NuCana faces a period of significant catalysts and challenges. With crucial clinical data on the horizon and a ...

NuCana plc faces persistent selling pressure following a substantial reverse stock split, with the oncology-focused company releasing a new investor ...

NuCana plc's stock continues its precipitous decline, marking a third consecutive day of substantial losses with no clear bottom in ...

NuCana plc has released its Q2 2025 financial and operational results, with the market now assessing the dual developments of ...